AI & Emerging Technology

With a robotic arm that lifts it from the water to charge itself, the new SPINO S1 Pro from MAMMOTION promises a truly autonomous pool care future.

A one-of-a-kind hot rod collection heads to Mecum Kissimmee 2026, with 100% of proceeds supporting Operation Healing Forces' critical mission.

Aegis Aerospace and United Semiconductors are building a chip factory in space. This Texas-backed venture could revolutionize tech and national security.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

A new alliance between Medtech Incubator and Leap Distributors promises to bridge the gap between device development and patient access in the U.S.

Amid rising grid complexity and cyber threats, Haivision's real-time video solutions aim to give utility operators unprecedented situational awareness.

In a strategic move to become a one-stop shop for medical implants, Resonetics acquires pulse generator tech, targeting the booming neuromodulation and BCI markets.

A major gold strike next to Nevada's famed Getchell Trend and the appointment of a renowned mine-finder signal a pivotal new chapter for Eminent Gold.

Early trial data for IKS014 reveals a high clinical benefit rate in pre-treated oesophageal cancer, offering a new beacon of hope for a hard-to-treat disease.

With a new $195M credit facility led by JPMorgan Chase, DailyPay strengthens its position in the evolving world of employee financial wellness.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Following a stellar Black Friday, Energizer is expanding its retail footprint and unveiling next-gen chargers at CES, challenging tech accessory giants.

Making its CES debut, Cearvol unveils smart glasses and open-ear aids powered by advanced AI, challenging the stigma of traditional hearing devices.

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

Emmaus Life Sciences outsources its sickle cell drug Endari® in North America to focus on global growth, as NeoImmuneTech gains a key U.S. market foothold.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

Apparel brand ATLAS 1 reopens with a collection focused on durability, not novelty, reflecting a major shift in urban fashion toward practical innovation.